PER 1.41% 7.0¢ percheron therapeutics limited

atl1103 development update, page-50

  1. 570 Posts.
    according to an article in yesterday's Fin Review ANP has less than 6 months cash runway. Management couldnt even consider going to phase 2 without funding sorted. CR is diffinitely on the way IMO

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.